These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 15948728)
1. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate. Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728 [TBL] [Abstract][Full Text] [Related]
2. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue. Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
4. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366 [TBL] [Abstract][Full Text] [Related]
5. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer. Heemers HV; Regan KM; Dehm SM; Tindall DJ Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004 [TBL] [Abstract][Full Text] [Related]
7. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093 [TBL] [Abstract][Full Text] [Related]
8. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival. Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms. Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929 [TBL] [Abstract][Full Text] [Related]
11. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887 [TBL] [Abstract][Full Text] [Related]
12. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. Trtková K; Pašková L; Matiješčuková N; Kolář Z Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266 [TBL] [Abstract][Full Text] [Related]
13. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
14. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cano P; Godoy A; Escamilla R; Dhir R; Onate SA Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex. Wang LG; Johnson EM; Kinoshita Y; Babb JS; Buckley MT; Liebes LF; Melamed J; Liu XM; Kurek R; Ossowski L; Ferrari AC Cancer Res; 2008 Apr; 68(8):2678-88. PubMed ID: 18413735 [TBL] [Abstract][Full Text] [Related]
16. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034 [TBL] [Abstract][Full Text] [Related]
17. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy. Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066 [TBL] [Abstract][Full Text] [Related]
18. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity. Hu XD; Meng QH; Xu JY; Jiao Y; Ge CM; Jacob A; Wang P; Rosen EM; Fan S Biochem Biophys Res Commun; 2011 Jan; 404(4):903-9. PubMed ID: 21172304 [TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen gene regulation by androgen receptor. Kim J; Coetzee GA J Cell Biochem; 2004 Oct; 93(2):233-41. PubMed ID: 15368351 [TBL] [Abstract][Full Text] [Related]
20. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]